GlaxoSmithKline
-
Pharma cos launch precision cancer consortium
To drive global access to comprehensive genomic testing for all patients with cancer The Precision Cancer Consortium (PCC) has announced…
Read More » -
GSK announces positive Phase III efficacy, safety data for daprodustat in patients with anaemia due to CKD
The programme enrolled over 8,000 patients who were treated for up to 4.26 years GlaxoSmithKline announced positive results from the…
Read More » -
CureVac’s COVID-19 vaccine triggers immune response in Phase I trial
CureVac is backed by German biotech investor Dietmar Hopp, the Gates Foundation and GlaxoSmithKline CureVac’s experimental COVID-19 vaccine triggered an…
Read More »